ZIM-Project TCR-specific Antigen Identification - TAgID

TAgID is an HSD project funded by the Central Innovation Programme for small and medium-sized enterprises (SMEs; Zentrales Innovationsprogramm Mittelstand, ZIM) in partnership with the Technical University of Berlin. The collaborative activities aim at developing an innovative approach for the identification of peptide/MHC-complexes recognized by tumor-specific T cell receptors (TCRs) (https://www.zim.de/ZIM/Navigation/DE/Meta/Englisch/englisch.html, Grant number: 16KN073238.)




Prof. Dr. Armin Gerbitz joins the HSDiagnomics advisory board

Armin is professor for “Hematology and Cellular Therapy” at the Dep. of Medicine 5, Hematology/Oncology, Hematopoietic Stem Cell Transplantation, University Hospital of Erlangen. For more than 15 years his main research focus lies in allogeneic hematopoietic stem cell transplantation, diagnostics and therapies of malignant lymphomas and leukemia, and therapy related problems like Graft-versus-Host-Disease (GvHD) and reactivation of latent herpes viruses. He is an expert in human and murine immune cell biology and has long-standing expertise in murine model systems. Within HSDiagnomis AG is a senior advisor for all aspects of T-cell profiling, related technologies, and upcoming applications in T-cell based treatments and diagnostics, e.g. novel tumor therapies.




HSDiagnomics launches TCRsafe T-cell profiling service

As of 10/31/2014 HSDiagnomics starts offering its TCRsafe T-cell profiling service to the research community. TCRsafe is the only T-cell profiling service world-wide, which provides rigorous deep-sequencing of the complete TCR-beta repertoire in combination with an inbuilt highly effective contamination protection system to eliminate even spurious alien DNA from input samples. The mission of HSDiagnomics will be to provide customers from clinical or research labs with a complete and very fast T-cell profiling service down to the single-cell level.




HSDiagnomics wins ProFIT grant provided by Investitionsbank Berlin (IBB)

We are very grateful to the IBB, the city of Berlin, and the European Union, that the concept of a novel method for T-cell profiling for research and diagnostic applications was elected for a 2 years period funding, which enabled HSDiagnomics to establish a molecular biology lab in Berlin-Steglitz and to develop and refine methods for deep TCRbeta-profiling. The ProFIT program is financed by the city of Berlin as well as by the European Union (EFRE, Europäischer Fonds für regionale Entwicklung).




HSDiagnomics enters partnership with Charite/Berlin

In the context of the ProFIT program (see above) HSDiagnomics and Charite Dept. of Molecular Pathology Prof. Michael Hummel, agreed on a close partnership for development of deep T-cell profiling technologies and pilot applications in a series of research projects, covering areas like lymphomas, GvHD, coeliac disease. A special focus will be on practical tests of HSDiagnomics double-contamination-protection system. (TCRsafe).